Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPT-SIOP-2000: Carboplatin vs Cyclophosphamide in Choroid Plexus Tumors
NCT00500890Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2005
- Primary completion
- Dec 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in choroid plexus tumor comparing Carboplatin Arm with Cyclophosphamide Arm (2 arms). Primary endpoint: Overall Survival. Started Sep 2005; status: terminated.
02
Drugs
carboplatincyclophosphamide
03
Conditions
choroid plexus tumor
Beyond the preview
Go deeper on NCT00500890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00500890.